Cargando…
The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study
BACKGROUND: The serum biomarker cancer antigen 125 (CA125) is widely used as an investigation for possible ovarian cancer in symptomatic women presenting to primary care. However, its diagnostic performance in this setting is unknown. We evaluated the performance of CA125 in primary care for the det...
Autores principales: | Funston, Garth, Hamilton, Willie, Abel, Gary, Crosbie, Emma J., Rous, Brian, Walter, Fiona M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592785/ https://www.ncbi.nlm.nih.gov/pubmed/33112854 http://dx.doi.org/10.1371/journal.pmed.1003295 |
Ejemplares similares
-
CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records
por: Funston, Garth, et al.
Publicado: (2021) -
Could Ovarian Cancer Prediction Models Improve the Triage of Symptomatic Women in Primary Care? A Modelling Study Using Routinely Collected Data
por: Funston, Garth, et al.
Publicado: (2021) -
Detecting ovarian cancer in primary care: can we do better?
por: Funston, Garth, et al.
Publicado: (2022) -
Identifying Ovarian Cancer in Symptomatic Women: A Systematic Review of Clinical Tools
por: Funston, Garth, et al.
Publicado: (2020) -
The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population
por: Barr, Chloe E., et al.
Publicado: (2022)